This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anja Schrade: Innovator in Antibody Technology
Introduction
Anja Schrade is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. Her innovative work has led to advancements in therapeutic applications, showcasing her expertise and dedication to scientific research.
Latest Patents
Anja Schrade holds a patent for a method for generating avid-binding multispecific antibodies. This patent describes a technique for enhancing the binding specificity of bispecific antibodies, which are designed to target two different cell-surface antigens. The method involves mutating specific amino acid residues in the binding sites to improve their affinity and specificity, thereby increasing the effectiveness of these therapeutic agents.
Career Highlights
Throughout her career, Anja has demonstrated a strong commitment to advancing antibody technology. Her work at Hoffmann-La Roche Inc. has positioned her as a key player in the biotechnology sector. With her innovative approach, she has contributed to the development of new therapeutic strategies that have the potential to improve patient outcomes.
Collaborations
Anja Schrade has collaborated with notable colleagues, including Guy Georges and Ulrich Brinkmann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Anja Schrade's contributions to the field of antibody technology exemplify her innovative spirit and dedication to scientific advancement. Her patent for generating avid-binding multispecific antibodies represents a significant step forward in therapeutic development. Through her work, she continues to inspire future innovations in biotechnology.